Registered entities
Exscientia Limited
Reg. No. SC428761United Kingdom
EXSCIENTIA PLC
Reg. No. 13483814United Kingdom
VERASAFE UNITED KINGDOM LTD
Reg. No. 12458059United Kingdom
EXSCIENTIA (UK) HOLDINGS LIMITED
Reg. No. 13555383Germany
SOPHOS LIMITED
Reg. No. 2096520Germany
RECURSION PHARMACEUTICALS, INC.
Reg. No. 1601830United States
Innovation
7 patent families (2 granted) — focus: Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 171 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 6 |
| 2023 | 1 |
| 2024 | 1 |
Investor mix
17 investors on record; lead investors include Novo Holdings, BlackRock, GT Healthcare Capital Partners, Bristol-Myers Squibb.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 24% |
| Private equity | 1 | 6% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 11 | 65% |